Evidence map›Paper›PMID 40370129›Full record

ArticleMicrobial biotechnology2025

A Novel Chitin-Based Purification System Using GAL1 Fusion Tags: Enhancing Recombinant Protein Production While Retaining Biological Activity.

Yao-Kuang Tseng, Yun-Heng Lu, Yun Liu, Zhi-Wei Weng, Yu-Tzu Lin, Chih-Hsuan Tsai, Yueh-Lung Wu, Rong-Nan Huang

Abstract read
In one paragraph

Article in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yao-Kuang TsengDepartment of Entomology, National Taiwan University, Taipei, Taiwan.
Yun-Heng LuDepartment of Entomology, National Taiwan University, Taipei, Taiwan.
Yun LiuDepartment of Entomology, National Taiwan University, Taipei, Taiwan.
Zhi-Wei WengDepartment of Entomology, National Taiwan University, Taipei, Taiwan.
Yu-Tzu LinDepartment of Entomology, National Taiwan University, Taipei, Taiwan.
Chih-Hsuan TsaiDepartment of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan.
Yueh-Lung WuDepartment of Entomology, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-3805-6515
Rong-Nan HuangDepartment of Entomology, National Taiwan University, Taipei, Taiwan.

Funding

National Science and Technology Council 113-2313-B-002-038-MY2National Science and Technology Council Grant Number: NSTC 111-2313-B-002 -038 -MY3
6 · The paper itself

Abstract

Efficient and economical purification methods are crucial for the commercial production of recombinant proteins with biomedical applications. In this study, we developed an affinity chromatography system that leverages the polysaccharide-binding properties of galectin-1 (GAL1) as a protein tag. The known GAL1-binding material, chitin, was used as the purification matrix. Melittin (MELT), a bee venom peptide known for its antimicrobial and anti-inflammatory properties with commercial potential, was chosen to validate this system. The GAL1-MELT fusion protein was expressed in Escherichia coli (E. coli) and successfully purified using a chitin-based matrix with sodium dodecyl sulfate (SDS) as a removable eluant. This method demonstrated higher purification efficiency compared to the His-tag/Ni-NTA approach, indicating that the GAL1/chitin system could serve as a superior alternative. The GAL1-MELT fusion protein retained strong antibacterial and anti-inflammatory activities, as well as collagen content modulation effects, confirming that MELT maintained its bioactivity. Apart from that, the GAL1-DsRed fusion protein was used as an additional protein target to evaluate the efficiency of the chitin-based column. Notably, all experiments were conducted without tag cleavage, showing that enzyme treatments for MELT isolation were unnecessary. This study highlights the potential of GAL1-polysaccharide interactions as a cost-effective and highly efficient alternative method for recombinant protein purification.

Indexed as

ChitinChromatography, AffinityGalectin 1Recombinant Fusion ProteinsAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsEscherichia coliMelittenMiceAnti-Bacterial AgentsAnti-Inflammatory AgentsChitinGalectin 1MelittenRecombinant Fusion Proteinsaffinity chromatographychitinGalectin‐1Melittinrecombinant protein purification

Identifiers

PMID40370129
PMCPMC12079018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.